Nanotechnology therapeutics may reshape autoimmune disease care with targeted delivery and immune modulation. Read more.

Infectious and parasitic disorders account for 9.7% of global mortality, with TB (2.3%), diarrheal bacterial infections (2%), meningitis (0.5%), encephalitis (0.2%), and bacterial sexually transmitted ...

DelveInsight's Nanomedicine Market Insights report provides the current and forecast market analysis, individual leading nanomedicine companies' market shares, challenges, nanomedicine market drivers, ...

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often ...

Nanomedicine involves the use of materials engineered at the 1–100 nm scale for healthcare and medical applications. The fundamental advantage of working at this scale is the ability to manipulate ...

Hepatic fibrosis is an abnormal wound-healing response triggered by chronic liver diseases, including non-alcoholic fatty liver disease, viral or alcoholic hepatitis, and Wilson’s disease. The ...

It is driven by the rising prevalence of chronic diseases. The global nanomedicine market is projected to more than double over the next decade, rising to $554b by 2034 from $227b in 2025, with an ...

(Nanowerk Spotlight) Cancer remains one of the most devastating and difficult to treat diseases, responsible for millions of deaths each year worldwide. While early screening and new targeted ...

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year. Now, ...

Fig. 1: Different drug release profile depending on the linker used for block-copolymers of nano-micellesFR-JQ1H/m with aliphatic aldehyde linker: Fast drug release in gradually elevated ...